Nowadays, the US Drug Enforcement Administration (DEA) classifies copyright as a Agenda II drug, recognizing its significant possible for abuse but nevertheless permitting its restricted use for healthcare needs. Having said that, latest pharmacoepidemiological trends suggest that copyright might be